{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:24:42Z","timestamp":1757701482411},"reference-count":27,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Dermatological Treatment"],"published-print":{"date-parts":[[2004,7,1]]},"DOI":"10.1080\/09546630410035329","type":"journal-article","created":{"date-parts":[[2004,7,15]],"date-time":"2004-07-15T18:08:31Z","timestamp":1089914911000},"page":"245-251","source":"Crossref","is-referenced-by-count":7,"title":["Combination therapy consisting of week pulses of oral terbinafine plus topical application of terbinafine cream in the treatment of onychomycosis"],"prefix":"10.1080","volume":"15","author":[{"given":"B","family":"Sanmano","sequence":"first","affiliation":[{"name":"Department of Dermatology, Juntendo University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Hiruma","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Juntendo University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Mizoguchi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Juntendo University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Juntendo University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,12]]},"reference":[{"key":"CIT0001","unstructured":"Kejda J, Itraconazole pulse therapy vs continuous terbinafine dosing for toenail onychomycosis.Postgrad Med1999; Spec No: 12\u201315."},{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3122\/15572625-13-4-268","volume":"13","author":"Harrell TK","year":"2000","journal-title":"J Am Board Fam Pract"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1439-0507.2001.00628.x","volume":"44","author":"Hiruma M","year":"2001","journal-title":"Mycoses"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1067\/mjd.2001.110644","volume":"44","author":"Gupta AK","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/09546630305541","volume":"14","author":"Jain S","year":"2003","journal-title":"J Dermatol Treat"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2340\/000155557300304","volume":"73","author":"Faergemann J","year":"1993","journal-title":"Acta Derm Venereol"},{"key":"CIT0007","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2165\/00003088-200140060-00005","volume":"40","author":"Debruyne D","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1046\/j.1365-2133.2002.04639.x","volume":"146","author":"Heikkila H","year":"2002","journal-title":"Br J Dermatol"},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0190-9622(96)80057-0","volume":"34","author":"Tosti A","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"CIT0010","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1346-8138.1996.tb04009.x","volume":"23","author":"Alpsoy E","year":"1996","journal-title":"J Dermatol"},{"key":"CIT0011","first-page":"1253","volume":"137","author":"Warshaw EM","year":"2001","journal-title":"Arch Dermatol"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200304010-00005"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70397-X"},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1525-1470.1998.1998015056.x","volume":"15","author":"Gupta AK","year":"1998","journal-title":"Pediatr Dermatol"},{"key":"CIT0015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1439-0507.1995.tb00051.x","volume":"38","author":"Albanese G","year":"1995","journal-title":"Mycoses"},{"key":"CIT0016","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1046\/j.1365-4362.2003.01678.x","volume":"42","author":"Gupta AK","year":"2003","journal-title":"Int J Dermatol"},{"key":"CIT0017","doi-asserted-by":"crossref","unstructured":"Evans EG, Drug synergies and the potential for combination therapy in onychomycosis.Br J Dermatol(2003) 149 (suppl 65): 11\u201313.","DOI":"10.1046\/j.1365-2133.149.s65.1.x"},{"key":"CIT0018","doi-asserted-by":"crossref","unstructured":"Olafsson JH, Sigurgeirsson B, Baran R, Combination therapy for onychomycosis.Br J Dermatol(2003) 149 (suppl 65): 15\u201318.","DOI":"10.1046\/j.1365-2133.149.s65.2.x"},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2133.2003.05381.x","volume":"149","author":"Rigopoulos D","year":"2003","journal-title":"Br J Dermatol"},{"key":"CIT0020","doi-asserted-by":"crossref","unstructured":"Evans EG, The rationale for combination therapy.Br J Dermatol(2001) 145 (suppl 60): 9\u201313.","DOI":"10.1046\/j.1365-2133.2001.145s60009.x"},{"key":"CIT0021","doi-asserted-by":"crossref","unstructured":"Baran R, Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosis.Br J Dermatol(2001) 145 (suppl 60): 15\u201319.","DOI":"10.1046\/j.1365-2133.2001.00045.x"},{"key":"CIT0022","doi-asserted-by":"crossref","unstructured":"Lecha M, Amorolfine and itraconazole combination for severe toenail onychomycosis; results of an open randomized trial in Spain.Br J Dermatol(2001) 145 (suppl 60): 21\u20136.","DOI":"10.1046\/j.1365-2133.2001.145s60021.x"},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1046\/j.1365-2133.2000.03545.x","volume":"142","author":"Baran R","year":"2000","journal-title":"Br J Dermatol"},{"key":"CIT0024","doi-asserted-by":"crossref","unstructured":"Reinel D, Clarke C, Comparative efficacy and safety of amorolfine nail lacquer 5% in onychomycosis, once- weekly versus twice-weekly.Clin Exp Dermatol(1992) 17 (suppl 1): 44\u20139.","DOI":"10.1111\/j.1365-2230.1992.tb00278.x"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(03)00025-1"},{"key":"CIT0026","doi-asserted-by":"crossref","unstructured":"Faergemann J, Baran R, Epidemiology, clinical presenta- tion and diagnosis of onychomycosis.Br J Dermatol(2003) 149 (suppl 65): 1\u20134.","DOI":"10.1046\/j.1365-2133.149.s65.4.x"},{"key":"CIT0027","doi-asserted-by":"crossref","unstructured":"Scher RK, Baran R, Onychomycosis in clinical practice: factors contributing to recurrence.Br J Dermatol(2003) 149 (suppl 65): 5\u20139.","DOI":"10.1046\/j.1365-2133.149.s65.5.x"}],"container-title":["Journal of Dermatological Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09546630410035329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T21:51:45Z","timestamp":1705182705000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09546630410035329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,1]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,7,1]]}},"alternative-id":["10.1080\/09546630410035329"],"URL":"https:\/\/doi.org\/10.1080\/09546630410035329","relation":{},"ISSN":["0954-6634","1471-1753"],"issn-type":[{"value":"0954-6634","type":"print"},{"value":"1471-1753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,1]]}}}